Advanced search
Publication Cover
Substance Abuse Volume 42, 2021 - Issue 4
Journal homepage
216
Views
3
CrossRef citations to date
0
Altmetric
Brief Reports

The role of overdose reversal training in knowing where to get naloxone: Implications for improving naloxone access among people who use drugs

Kristin E. Schneidera Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5813-1327View further author information
, PhDORCID Icon,
Lauren Daytonb Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information
, MSPH,
Abigail K. Winikerb Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAORCID Iconhttps://orcid.org/0000-0002-0146-1920View further author information
, MSPHORCID Icon,
Karin E. Tobinb Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information
, PhD &
Carl A. Latkinb Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAORCID Iconhttps://orcid.org/0000-0002-7931-2116View further author information
, PhDORCID Icon
Pages 438-443 | Published online: 22 Feb 2021

References

  • National Institute on Drug Abuse. Overdose Death Rates. Trends and Statistics Web site. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Published 2018. Updated August 2018.
  • Wilson N, Kariisa M, Seth P, Smith H, Davis ML. Drug and opioid-involved overdose deaths—United States. MMWR Morb Mortal Wkly Rep. 2017;69:2018.
  • O’Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region - United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66(34):897–903.
  • Vivolo-Kantor AM, Seth P, Gladden RM, et al. Vital signs: trends in emergency department visits for suspected opioid Overdoses - United States, July 2016-September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279–285.
  • Levine M, Sanko S, Eckstein M. Assessing the risk of prehospital administration of naloxone with subsequent refusal of care. Prehosp Emerg Care. 2016;20(5):566–569.
  • McDonald R, Campbell ND, Strang J. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation. Drug Alcohol Depend. 2017;178:176–187.
  • Elzey MJ, Fudin J, Edwards ES. Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems. Expert Opin Drug Deliv. 2017;14(9):1045–1058.
  • Robinson A, Wermeling DP. Intranasal naloxone administration for treatment of opioid overdose. Am J Health Syst Pharm. 2014;71(24):2129–2135.
  • Wheeler E, Jones TS, Gilbert MK, Davidson PJ, Centers for Disease Control and Prevention (CDC). Opioid overdose prevention programs providing naloxone to laypersons—United States. MMWR Morb Mortal Wkly Rep. 2015;64(23):631–635.
  • Davis C, Carr D. State legal innovations to encourage naloxone dispensing. J Am Pharm Assoc (2003). 2017;57(2S):S180–S184.
  • Bailey AM, Wermeling DP. Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings. Ann Pharmacother. 2014;48(5):601–606.
  • Bessen S, Metcalf SA, Saunders EC, et al. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA. Int J Drug Policy. 2019;74:144–151.
  • Donovan E, Case P, Bratberg JP, et al. Beliefs associated with pharmacy-based naloxone: a qualitative study of pharmacy-based naloxone purchasers and people at risk for opioid overdose. J Urban Health. 2019;96(3):367–378.
  • Meyerson BE, Agley JD, Davis A, et al. Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016. Drug Alcohol Depend. 2018;188:187–192.
  • Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013;48(8):590–599.
  • Khatiwoda P, Proeschold-Bell RJ, Meade CS, Park LP, Proescholdbell S. Facilitators and barriers to naloxone kit use among opioid-dependent patients enrolled in medication assisted therapy clinics in North Carolina. N C Med J. 2018;79(3):149–155.
  • StataCorp L. Stata Statistical Software (Version Release 14). College Station, TX: StataCorp LP; 2015.
  • Baltimore City Health Department. Baltimore City Overdose Prevention and Response Information. https://health.baltimorecity.gov/opioid-overdose/baltimore-city-overdose-prevention-and-response-information. Published 2018.
  • Graves RL, Andreyeva E, Perrone J, Shofer FS, Merchant RM, Meisel ZF. Naloxone availability and pharmacy staff knowledge of standing order for naloxone in Pennsylvania pharmacies. J Addict Med. 2019;13(4):272–278.
  • Guadamuz JS, Alexander GC, Chaudhri T, Trotzky-Sirr R, Qato DM. Availability and cost of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 2017. JAMA Netw Open. 2019;2(6):e195388–e195388.
  • Office of Pharmacy Services Medicaid Pharmacy Program. Baltimore, Maryland: Maryland Department of Health; 2019.
  • Cressman AM, Mazereeuw G, Guan Q, Jia W, Gomes T, Juurlink DN. Availability of naloxone in Canadian pharmacies: a population-based survey. CMAJ Open. 2017;5(4):E779–E784.
  • Darracq MA, Lee J, Wilson T, Lasoff D, Armenian P. Pharmacist dispensed naloxone: knowledge, availability, participation and cost in selected California counties. Int J Drug Policy. 2019;71:113–117.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.